logo
Billy Joel, 76, breaks silence on his brain disorder and how it forced him to step back from music

Billy Joel, 76, breaks silence on his brain disorder and how it forced him to step back from music

Daily Mail​3 days ago
Billy Joel gave an emotional update on his health amid his battle with the brain disorder normal pressure hydrocephalus (NPH).
He revealed his diagnosis in May, and announced the cancellation of his forthcoming concerts following recent onstage struggles.
The condition's impacted the 76-year-old's 'hearing, vision, and balance', and he opened up about his condition on Monday's Club Random With Bill Maher podcast, where he said: 'I feel fine. My balance sucks. It's like being a boat.'
Joel said doctors could not identify the cause of the condition, and said: 'They don't know… I thought it must be from drinking.'
Over the years, Joel's been open about his struggles with alcohol and substance abuse, as well as his battles with mental health, which at one point led to a suicide attempt amid career pressures.
He said: 'I feel good. They keep referring to what I have as a brain disorder, so it sounds a lot worse than what I'm feeling.'
According to Mayo Clinic: 'Hydrocephalus is the buildup of fluid in the brain, enlarging the ventricles and puts pressure on brain tissue, potentially causing damage and neurological symptoms.'
Joel underwent targeted physical therapy as prescribed by his doctor and was 'advised to refrain from performing during this recovery period'.
When diagnosed early, NPH could be effectively treated with surgery to drain excess fluid from the brain to relieve pressure and the symptoms.
However, if left untreated, the condition could cause permanent damage later on.
The musical legend also expressed his gratitude for the care he had received and thanked fans for their continued support.
Joel said on Instagram: 'I'm sincerely sorry to disappoint our audience, and thank you for understanding.'
A statement added: 'Billy is thankful for the excellent care he is receiving and is fully committed to prioritizing his health.'
Opening up: The singer used Instagram to share details of his diagnosis
The post added: 'He is grateful for the support from fans during this time and looks forward to the day when he can once again take the stage.'
The new health update was after Joel previously postponed his tour by only four months 'due to a medical condition'.
A statement on Instagram on March 11 revealed the tour had been halted after Joel underwent a recent surgery: 'The current tour will be postponed for four months to allow him to recover from recent surgery and to undergo physical therapy under the supervision of his doctors.
'Joel is expected to make a full recovery.'
The star posted: 'While I regret postponing any shows, my health must come first. I look forward to getting back on stage and sharing the joy of live music with our amazing fans. Thank you for your understanding.'
Multiple fans speculated if his medical issues were connected to a recent fall on stage.
In late February, Joel suffered a nasty fall during a gig at the Mohegan Sun resort in Connecticut, which sparked major fear amongst fans.
Footage from the show captured the Grammy-winner as he spun a mic stand before he hurled it across the stage - only to suddenly topple over moments later.
Photos and clips of the fall captured Joel as he appeared to stumble before hitting the stage hard on his side, then rolling on to his back.
Joel was helped up and managed to carry on with the rest of the show.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Paramount Global says Skydance merger should close in two weeks
Paramount Global says Skydance merger should close in two weeks

Reuters

time12 minutes ago

  • Reuters

Paramount Global says Skydance merger should close in two weeks

July 25 (Reuters) - Paramount Global (PARA.O), opens new tab said on Friday it expects to complete its merger with Skydance Media by August 7, following government approval for the $8.4 billion deal. Skydance CEO David Ellison is prepared to assume the helm at Paramount, home to the venerable Paramount Pictures, the CBS broadcast network, and a collection of cable television channels. The new chief executive already is confronted with questions from investors about the future of the Paramount+ streaming service, plans for Paramount's declining television assets, and forecasts for spending on content -- including professional sports. "Now that the long, drawn-out sale process is finally nearing its end, Skydance leadership is poised to take control," wrote MoffettNathanson media analyst Robert Fishman. "With that, the real work begins -- rebuilding Paramount, addressing the critical strategic questions ahead, and charting a path toward a more sustainable and competitive future." Announced more than a year ago, the merger will unite Paramount's prized film and TV library including classics such as "Ferris Bueller's Day Off" and "Breakfast at Tiffany's," with films it produced with Skydance, including "Top Gun: Maverick" and "Mission: Impossible – Dead Reckoning." Ellison was not available for comment. He has previously said he plans to expand Paramount's technological capabilities, rebuild the Paramount+ platform and grow the streaming business, and reorganize the business to prioritize cash flow. A year ago, he said the team had identified $2 billion in cost savings. The Federal Communications Commission cleared the deal on Thursday, just weeks after Paramount settled a lawsuit filed by U.S. President Donald Trump over CBS' editing of a "60 Minutes" interview with his Democratic opponent, former Vice President Kamala Harris. The $16-million settlement drew criticism that Paramount had effectively bought regulatory approval, with the Democratic dissenter in the FCC's 2-1 vote calling it a "cowardly capitulation" to the Trump administration. The agency has repeatedly said its review was independent of the lawsuit.

Atai Life Sciences schizophrenia drug fails to meet main goal in trial
Atai Life Sciences schizophrenia drug fails to meet main goal in trial

Reuters

time12 minutes ago

  • Reuters

Atai Life Sciences schizophrenia drug fails to meet main goal in trial

July 25 (Reuters) - Atai Life Sciences ( opens new tab and its partner Recognify Life Sciences said on Friday their experimental drug did not meet the main goal in a mid-stage trial for patients with cognitive impairment linked to schizophrenia. U.S.-listed shares of atai fell about 14% in extended trading. Recognify said patients taking the drug, inidascamine, showed some improvement in cognitive tests compared with a placebo, but the results were not statistically significant. The trial enrolled 242 patients with cognitive impairment associated with schizophrenia, which affects memory, attention and decision-making in people with the mental illness. Despite the drug missing the main goal, Recognify said patients on inidascamine showed consistent signs of improvement in areas such as processing speed and verbal learning, with positive trends on a test assessing real-world cognitive abilities.

Health Secretary Kennedy to oust advisory panel on cancer screenings, HIV prevention drugs, WSJ reports
Health Secretary Kennedy to oust advisory panel on cancer screenings, HIV prevention drugs, WSJ reports

Reuters

time12 minutes ago

  • Reuters

Health Secretary Kennedy to oust advisory panel on cancer screenings, HIV prevention drugs, WSJ reports

July 25 (Reuters) - Health Secretary Robert F. Kennedy Jr. is planning to remove all the members of an advisory panel that determines what cancer screenings and other preventive health measures insurers must cover, the Wall Street Journal reported on Friday, citing people familiar with the matter. Kennedy plans to dismiss all 16 panel members of the U.S. Preventive Services Task Force, according to the WSJ report. The task force's members are selected by the U.S. Secretary Of Health And Human Services without Senate confirmation. The HHS did not immediately respond to a Reuters request for comment.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store